M24-533 Phase 2, randomized master protocol study to evaluate safety and efficacy of multiple treatment combinations with telisotuzumab adizutecan in subjects with mets colorectal cancer

  • Phase II
  • Trial Category: Gastrointestinal

Contact(s)

Mary Beth Wilwerding, RN   Admin@NEcancertrials.com

Location(s)

Available at Nebraska Cancer Specialists, Omaha and Grand Island, NE locations

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*